PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover key gene for toxic alkaloid in barley

Joint press release of the IPK Leibniz Institute and the Leibniz University Hannover

2024-03-28
(Press-News.org) All plants mediate their environmental interactions via chemical signals. An example is the alkaloid gramine produced by barley, one of the world’s most widely grown cereals. Gramine provides protection against herbivorous insects and grazing animals and inhibits the growth of other plants. Despite long-standing interest, the key gene for the formation of gramine remained elusive.

The researchers discovered a cluster of two genes in barley for gramine biosynthesis. The first gene (HvNMT) had already been discovered 18 years ago. In their study the researchers from IPK and the Leibniz University Hannover now identified a second gene (AMI synthase, HvAMIS), and found out that both genes are located in proximity of each other on the same chromosome. With this discovery, the pathway of gramine biosynthesis is now fully elucidated.

“We discovered that AMIS is an oxidase enzyme that carries out an unusual cryptic oxidative rearrangement of tryptophan, allowing us to revise the previous biosynthetic proposal from the 1960s”, says Dr. John D’Auria, head of IPK’s research group “Metabolic Diversity”. Prof. Dr. Jakob Franke, head of the group “Biochemistry of Plant Specialised Metabolites” at Leibniz University Hannover, adds: “We were very surprised by the so far unknown enzyme mechanism by which gramine is formed. At the same time, we now have the possibility to produce biologically active alkaloids with sustainable biotechnological methods.”

The research team could produce gramine in yeast and model plants (Nicotiana benthamiana, Arabidopsis). “In contrast to many other protective metabolites from plants, production of gramine requires only two genes. Therefore, using our findings for practical applications is relatively straightforward”, emphasises Ling Chuang from Leibniz University Hannover, one of the first authors. “Furthermore, genetic engineering of barley allowed us to produce gramine in a non-gramine producing barley variety, and eliminate gramine production in a gramine producing barley variety by genome editing”, explains the other first author Sara Leite Dias, International Max Planck Research School funded researcher at the IPK.

“The results set the basis to produce gramine in organisms without the native ability to synthesize it for purposes such as a natural plant protection agent, or to eliminate gramine from barley and other grasses to reduce toxicity towards ruminants”, says Dr. John D’Auria. “Our findings set the ground for improving barley to increase its resistance to pests, reduce its toxicity to ruminants and contribute to sustainable weed management.”

Original publication:

Leite Dias et al. (2024): Biosynthesis of the allelopathic alkaloid gramine in barley by a cryptic oxidative rearrangement. Science. DOI: 10.1126/science.adk6112

Scientific Contact: 
Dr. John D’Auria: Phone: +49 39482 5176; dauria@ipk-gatersleben.de
Prof. Dr. Jakob Franke: Phone: +49 511 762 2628 jakob.franke@botanik.uni-hannover.de

END


ELSE PRESS RELEASES FROM THIS DATE:

New approach to monitoring freshwater quality can identify sources of pollution, and predict their effects

New approach to monitoring freshwater quality can identify sources of pollution, and predict their effects
2024-03-28
The source of pollutants in rivers and freshwater lakes can now be identified using a comprehensive new water quality analysis, according to scientists at the University of Cambridge and Trent University, Canada. Microparticles from car tyres, pesticides from farmers’ fields, and toxins from harmful algal blooms are just some of the organic chemicals that can be detected using the new approach, which also indicates the impact these chemicals are likely to have in a particular river or lake. Importantly, the approach can also point to the origin of specific organic matter dissolved in the water, because it has a distinct ...

Bidirectional link between premenstrual disorders and perinatal depression

2024-03-28
Women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD) have a higher risk of perinatal depression. Conversely, women with perinatal depression have a higher risk of developing premenstrual disorders. This is shown in a study from Karolinska Institutet published in the journal PLOS Medicine. Premenstrual disorders like PMS or PMDD and perinatal depression are similar in the way that symptoms appear in connection with hormonal changes. This fact has given rise to the hypothesis ...

Cell division quality control ‘stopwatch’ uncovered

Cell division quality control ‘stopwatch’ uncovered
2024-03-28
Each day, hundreds of billions of cells in our body cycle through a period of growth and division. Yet in that time, only about 30 minutes is spent on the critical orchestration of mitosis, when chromosomes are carefully segregated from one parent cell to the next generation of two daughter cells. It’s during this crucial period of cell division that things can go haywire. Chromosomes can be misdirected, leading to damaged and diseased cells that progress to different types of cancer. University of California San Diego scientists reporting in the journal Science have found a key mechanism that keeps track of mitosis timing and ...

Vaccine protects cattle from bovine tuberculosis, may eliminate disease

Vaccine protects cattle from bovine tuberculosis, may eliminate disease
2024-03-28
UNIVERSITY PARK, Pa. — Bovine tuberculosis (TB) is a livestock disease that results in large economic losses to animal agriculture worldwide. The disease can also transmit to humans and cause severe illness and death. Researchers from Penn State, Addis Ababa University and the University of Cambridge have now demonstrated that a vaccine for TB currently used in humans significantly reduces infectiousness of vaccinated livestock, improving prospects for elimination and control. The study published today (March 28) in the journal Science.  The spillover ...

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award
2024-03-28
March 28, 2024, Mountain View, CA -- The SETI Institute is pleased to announce that Dr. Andrew Siemion will be honored with the prestigious 2024 Drake Award for his exceptional and pioneering contributions to SETI and radio astronomy and his leadership in the field. Siemion's distinguished career includes his role as the Bernard M. Oliver Chair for SETI at the SETI Institute, Principal Investigator for the Breakthrough Listen Initiative at the University of Oxford, along with holding an Honorary Professorship ...

New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells

2024-03-28
Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo haemorrhagic fever virus enters our cells. The results are published in Nature Microbiology and are an important step in the development of drugs against the deadly disease. Crimean-Congo haemorrhagic fever virus (CCHF virus) is spread through tick bites and can cause haemorrhagic fever. The disease is serious and has a mortality rate of up to 40 per cent depending on the health status of the person infected. Common symptoms ...

Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma

2024-03-28
In a recent multi-center study published in the Journal of the National Cancer Institute, researchers examined the effects of neoadjuvant chemotherapy (NAC) on patients suffering from locally advanced penile squamous cell carcinoma (PSCC). Dr. Kyle Rose, urologic oncologist at Ochsner MD Anderson Cancer Center, was the lead author for the publication. The research included a cohort of 209 patients undergoing NAC, targeting locally advanced and clinically node positive PSCC. The patient group showed a diverse range of disease severity, with a distribution including 7% with stage II, 48% with stage III, and 45% with stage IV PSCC, ...

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
2024-03-28
(MEMPHIS, Tenn. – March 28, 2024) Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children’s Research Hospital scientists demonstrated that in bilateral Wilms tumor (cancer in both kidneys) chemotherapy resistance can point toward a more favorable histology and an ultimatelygood outcome. The study revealed that tumors that do not respond to neoadjuvant, or tumor-shrinking, chemotherapy are predominantly ...

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

2024-03-28
HERSHEY, Pa. — Despite evidence that financial conflicts of interest may influence medical practice and research and may erode patient trust in medical professionals, these relationships remain pervasive. According to a new analysis of the Open Payments platform, a database that tracks payments between physicians and industry, a team led by a Penn State researcher found that doctors received approximately $12.1 billion from drug and device makers between 2013 and 2022.  Their findings published today (March 28) in JAMA. It’s one of the first studies to look at industry payments longitudinally and by specialty.  “Overall, ...

Discovery suggests new strategy against follicular lymphoma

2024-03-28
A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients. The study, published March 7 in Cancer Cell, showed that while mutations affecting a gene-regulating complex called BAF can put the cancer on a dangerous trajectory, they also make follicular lymphoma highly susceptible to experimental BAF-inhibitor drugs. “These encouraging findings could address critical and urgent challenges with this disease and have prompted us to begin planning clinical trials ...

LAST 30 PRESS RELEASES:

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

Antimicrobial resistance crisis: “Antibiotics are not magic bullets”

Florida dolphin found with highly pathogenic avian flu: Report

Barcodes expand range of high-resolution sensor

DOE Under Secretary for Science and Innovation visits Jefferson Lab

Research expo highlights student and faculty creativity

Imaging technique shows new details of peptide structures

MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center

Tomography-based digital twins of Nd-Fe-b magnets

People with rare longevity mutation may also be protected from cardiovascular disease

Mobile device location data is already used by private companies, so why not for studying human-wildlife interactions, scientists ask

Test reveals mice think like babies

[Press-News.org] Researchers discover key gene for toxic alkaloid in barley
Joint press release of the IPK Leibniz Institute and the Leibniz University Hannover